Marcello Arca, Italy
Sapienza University of Rome Department of Internal Medicine and Medical Specialties
Moderator of 1 Session
Session Type
Industry Sponsored Session
Room
Industry session hall
Date
07.10.2020, Wednesday
Session Time
13:15 - 14:00
Session Description
Not included in the CME/ CPD accredited programme
Session Evaluation
Option 1
[{"name":"Introduction","mode":"playlist","public":true,"info":{"id":1757,"presentation":"Introduction","session":"Not included in the main CME-CPD of the event","presenter":"Marcello Arca, Italy","photo":""},"playlist":[{"name":"Introduction","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/165\/NEW_Marcelo Arca EAS20 1757 Introduction.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/165\/NEW_Marcelo Arca EAS20 1757 Introduction.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/165\/DBAE7D11.jpg","data":[],"tracks":[]}]},{"name":"Finding HoFH \u2013 is a rare disease hard to find?","mode":"playlist","public":true,"info":{"id":1758,"presentation":"Finding HoFH \u2013 is a rare disease hard to find?","session":"Not included in the main CME-CPD of the event","presenter":"Mary McGowan, United States of America","photo":""},"playlist":[{"name":"Finding HoFH \u2013 is a rare disease hard to find?","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/165\/P1758.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/165\/P1758.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/165\/504BB765.jpg","data":[],"tracks":[]}]},{"name":"Lomitapide effectiveness and tolerability in patients with homozygous familial hypercholesterolaemia \u2013 updated data from an Italian cohort","mode":"playlist","public":true,"info":{"id":1759,"presentation":"Lomitapide effectiveness and tolerability in patients with homozygous familial hypercholesterolaemia \u2013 updated data from an Italian cohort","session":"Not included in the main CME-CPD of the event","presenter":"Laura D'Erasmo, Italy","photo":""},"playlist":[{"name":"Laura DErasmo - EAS20 - 1759 - Lomitapide effectiveness and tolerability in patients with homozygous","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/165\/Laura DErasmo - EAS20 - 1759 - Lomitapide effectiveness and tolerability in patients with homozygous familial hypercholesterolaemia-EDITED-FINAL.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/165\/Laura DErasmo - EAS20 - 1759 - Lomitapide effectiveness and tolerability in patients with homozygous familial hypercholesterolaemia-EDITED-FINAL.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/165\/45E0DF51.jpg","data":[],"tracks":[]}]},{"name":"Lomitapide hepatic data in HoFH \u2013 a hepatologists perspective","mode":"playlist","public":true,"info":{"id":1760,"presentation":"Lomitapide hepatic data in HoFH \u2013 a hepatologists perspective","session":"Not included in the main CME-CPD of the event","presenter":"Dominique Larrey, France","photo":""},"playlist":[{"name":"LARREY DOMINIQUE - EAS20-ID1760 - Lomitapide hepatic data in HoFH \u2013 a hepatologists perspective","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/165\/1760.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/165\/1760.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/165\/B4F232E7.jpg","data":[],"tracks":[]}]},{"name":"Q&A","mode":"playlist","public":true,"info":{"id":1761,"presentation":"Q&A","session":"Not included in the main CME-CPD of the event","presenter":"Marcello Arca, Italy, Mary McGowan, United States of America, Laura D'Erasmo, Italy, Dominique Larrey, France","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/165\/The Changing Face of HoFH.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/165\/The Changing Face of HoFH.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/165\/2A2A6EAF.jpg","data":[],"tracks":[]}]}]
{"type":2,"code":"7E32Xi03R"}
[session]
[presentation]
[presenter]
Presenter of 6 Presentations
Expert and patient insights: interactive Q&A, summary and closing remarks
Session Type
Industry Sponsored Session
Session Time
12:30 - 14:00
Lecture Time
13:30 - 14:00
[{"name":"Expert and patient insights: interactive Q&A, summary and closing remarks","mode":"playlist","public":true,"info":{"id":1765,"presentation":"Expert and patient insights: interactive Q&A, summary and closing remarks","session":"Not included in the main CME-CPD of the event","presenter":"Pedro Valdivielso Felices, Spain, Jill Prawer, United Kingdom, Marcello Arca, Italy, Alan Jones, United Kingdom","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/166\/FCS and me Living with a rare lipid disorder.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/166\/FCS and me Living with a rare lipid disorder.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/166\/58BA02FD.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"6E22Xi0wr"}
[session]
[presentation]
[presenter]
Introduction
Session Type
Industry Sponsored Session
Date
07.10.2020, Wednesday
Session Time
13:15 - 14:00
Lecture Time
13:15 - 13:18
[{"name":"Introduction","mode":"playlist","public":true,"info":{"id":1757,"presentation":"Introduction","session":"Not included in the main CME-CPD of the event","presenter":"Marcello Arca, Italy","photo":""},"playlist":[{"name":"Introduction","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/165\/NEW_Marcelo Arca EAS20 1757 Introduction.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/165\/NEW_Marcelo Arca EAS20 1757 Introduction.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/165\/DBAE7D11.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"8E22Xi0wi"}
[session]
[presentation]
[presenter]
Treatment of FCS with an antisense oligonucleotide (volanesorsen) and the APPROACH study
Session Type
Industry Sponsored Session
Session Time
12:30 - 14:00
Lecture Time
12:55 - 13:15
[{"name":"Treatment of FCS with an antisense oligonucleotide (volanesorsen) and the APPROACH study","mode":"playlist","public":true,"info":{"id":1764,"presentation":"Treatment of FCS with an antisense oligonucleotide (volanesorsen) and the APPROACH study","session":"Not included in the main CME-CPD of the event","presenter":"Marcello Arca, Italy","photo":""},"playlist":[{"name":"Marcello Arca - EAS20- ID1764 - Tratment of FCS with an antisense oligonucleotide ( volanesorsen) an","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/166\/1764.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/166\/1764.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/166\/AA452F24.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"aE22Xi0wq"}
[session]
[presentation]
[presenter]
Q&A
Session Type
Industry Sponsored Session
Date
07.10.2020, Wednesday
Session Time
13:15 - 14:00
Lecture Time
13:53 - 14:00
[{"name":"Q&A","mode":"playlist","public":true,"info":{"id":1761,"presentation":"Q&A","session":"Not included in the main CME-CPD of the event","presenter":"Marcello Arca, Italy, Mary McGowan, United States of America, Laura D'Erasmo, Italy, Dominique Larrey, France","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/165\/The Changing Face of HoFH.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/165\/The Changing Face of HoFH.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/165\/2A2A6EAF.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"7E22Xi0wn"}
[session]
[presentation]
[presenter]
ANGPTL 3 what we have learned from genetics?
Session Time
17:30 - 19:00
Lecture Time
17:53 - 18:13
[{"name":"ANGPTL 3 what we have learned from genetics?","mode":"playlist","public":true,"info":{"id":1520,"presentation":"ANGPTL 3 what we have learned from genetics?","session":"New ways to modulate TG metabolic pathways","presenter":"Marcello Arca, Italy","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/109\/Marcello Arca - EAS20 - 1520 - ANGPTL3, what we have learned from genetics.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/109\/Marcello Arca - EAS20 - 1520 - ANGPTL3, what we have learned from genetics.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/109\/89838088.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"6E22Xi0sd"}
[session]
[presentation]
[presenter]
Panel Discussion
Session Time
17:30 - 19:00
Lecture Time
18:33 - 18:48
[{"name":"Panel Discussion","mode":"playlist","public":true,"info":{"id":1522,"presentation":"Panel Discussion","session":"New ways to modulate TG metabolic pathways","presenter":"Christoph J. Binder, Austria, Arnold Von Eckardstein, Switzerland, Marcello Arca, Italy, Daniel Gaudet, Canada, Sander Kersten, Netherlands","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5228.jpg"},"playlist":[{"name":"Panel Discussion","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/109\/Panel Discussion.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/109\/Panel Discussion.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/109\/4797E3E3.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"8E22Xi0sf"}
[session]
[presentation]
[presenter]
